1. Home
  2. AIMD vs DSS Comparison

AIMD vs DSS Comparison

Compare AIMD & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • DSS
  • Stock Information
  • Founded
  • AIMD 1984
  • DSS 1984
  • Country
  • AIMD United States
  • DSS United States
  • Employees
  • AIMD N/A
  • DSS N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • AIMD Health Care
  • DSS Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • DSS Nasdaq
  • Market Cap
  • AIMD 8.5M
  • DSS 7.3M
  • IPO Year
  • AIMD N/A
  • DSS N/A
  • Fundamental
  • Price
  • AIMD $0.74
  • DSS $0.95
  • Analyst Decision
  • AIMD
  • DSS
  • Analyst Count
  • AIMD 0
  • DSS 0
  • Target Price
  • AIMD N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • AIMD 379.0K
  • DSS 18.3K
  • Earning Date
  • AIMD 03-07-2025
  • DSS 03-26-2025
  • Dividend Yield
  • AIMD N/A
  • DSS N/A
  • EPS Growth
  • AIMD N/A
  • DSS N/A
  • EPS
  • AIMD N/A
  • DSS N/A
  • Revenue
  • AIMD $40,633.00
  • DSS $25,019,000.00
  • Revenue This Year
  • AIMD N/A
  • DSS N/A
  • Revenue Next Year
  • AIMD N/A
  • DSS N/A
  • P/E Ratio
  • AIMD N/A
  • DSS N/A
  • Revenue Growth
  • AIMD N/A
  • DSS N/A
  • 52 Week Low
  • AIMD $0.40
  • DSS $0.77
  • 52 Week High
  • AIMD $3.10
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 59.44
  • DSS 56.49
  • Support Level
  • AIMD $0.57
  • DSS $0.81
  • Resistance Level
  • AIMD $0.77
  • DSS $0.97
  • Average True Range (ATR)
  • AIMD 0.06
  • DSS 0.07
  • MACD
  • AIMD -0.00
  • DSS 0.01
  • Stochastic Oscillator
  • AIMD 68.48
  • DSS 81.82

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: